2 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Active not recruiting 1, Recruiting 1, Unknown 1 |
Follow Hemophilia: new trials by email Literature Review of Hemophilia trials Research Report on Hemophilia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A） PCC - Hemophilia, Inhibitors | Phase 4 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 30 | 2026-03-01 | 2026-02-12 |
| A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis Efanesoctocog alfa - Haemophilia A (Moderate or Severe), Hemophilia, Classic | Phase 4 | Active not recruiting | Swedish Orphan Biovitrum | 37 | 2024-12-19 | 2026-04-30 |
| Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients combination between moderate to vigorous-intensity physical activities and pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis, pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis alone - Hemophilia | Phase 4 | Completed | Chulalongkorn University | 13 | 2022-07-01 | 2023-02-15 |
| The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients Albutrepenonacog Alfa 1 UNT [IDELVION] - Hemophilia | Phase 4 | Unknown | National Taiwan University Hospital | 5 | 2020-04-21 | 2020-10-30 |
| Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin) - Hepatitis C, Hemophilia | Phase 4 | Completed | Baqiyatallah Medical Sciences University | 400 | 2007-03-01 | 2009-09-17 |
Hemophilia A (5) · Hepatitis C (1) · Lymphoma, Follicular (1) · Synovitis (1)
Blood Coagulation Disorders (5) · Blood Coagulation Disorders, Inherited (5) · Coagulation Protein Disorders (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Hemorrhagic Disorders (5) · Blood-Borne Infections (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Immune System Diseases (1)
Ribavirin (1) · albutrepenonacog alfa (1) · peginterferon alfa-2a (1)
Baqiyatallah Medical Sciences University (1) · Chulalongkorn University (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · National Taiwan University Hospital (1) · Swedish Orphan Biovitrum (1)
China (1) · Iran (1) · Italy (1) · Norway (1) · Spain (1) · Sweden (1) · Taiwan (1) · Thailand (1)
Bashir HajiBeigi, M.D. (1) · Bita Behnava, M.D. (1) · Fariborz Mansour-Ghanaei, M.D. (1) · Maryam Keshvari, M.D. (1) · Mohammad Hossein Somi, M.D. (1) · Pegah Karimi, M.D. (1) · Professor Seyed-Moayed Alavian, Professor (1) · Seyyed Mohammad Miri, M.D. (1)